Dylan Essner on Documentation Tools for CAR T-Cell Therapy

Article

Dylan Essner discussed the implementation of documentation tools and CRS, ICANS and ICE flow sheets within CAR T-cell therapy.

Dylan Essner, an Epic Beacon Analyst at Washington University in St. Louis, talked about his work in implementing new documentation tools to streamline data for patients.

Transcription:

Within the CAR T(-cell) build in Epic, I helped mainly with the documentation tools for flow sheets. We have the CRS, ICANS and the ICE flow sheets, and I built all 3 of those flow sheets and included them in 1 flow sheet template that way the providers and nurses can go in and document their ICE, ICANS and CRS documentation. And then some of those--the ICANS and the ICE--have a formula built into the flow sheets that allows it to auto-populate the grade and score of the actual documentation. They just put in the different data points for each flow sheet and then we have a row at the bottom that auto-calculates the grade for each patient, so they don’t have to go in and do that.

And then for CRS they actually have to go in and we give them an informational chart they can look at, and then from there they can grade the patient from the bottom row. With that flow sheet data, we also built some smart links that pull the data from those flow sheets into the progress notes, so it automatically just populates into their progress notes making documentation for them a lot easier.

Related Videos
David Suhy, PhD, the cofounder and chief scientific officer of Earli
Deepak L. Bhatt, MD, MPH, MBA, on Incorporating AI into Genetic Research for Cardiovascular Disease
Jeffrey Chamberlain, PhD, on Helping Progress Cell and Gene Therapy Development
Jonathan W. Weinsaft, MD, on Integrating Genetic Research into Cardiovascular Medicine
Jacques Galipeau, MD, on Highlights from ISCT 2024’s Presidential Plenary
Vanee Pho, PhD, the senior director of product management, cell and gene therapy, at Mission Bio
Michael Wang, MD, a professor in the Department of Lymphoma/Myeloma at MD Anderson Cancer Center
Robert J. Hopkin, MD, on Looking Deeper into Fabry Disease Biology
Steven W. Pipe, MD, on Confirming Efficacy, Safety of Hemgenix Gene Therapy in Hemophilia B Populations
Rawan Faramand, MD, an assistant professor at Moffit Cancer Center
© 2024 MJH Life Sciences

All rights reserved.